Home > Insider Trading > Filing (0001144204-15-035361)

Filing Details

Accession Number:: 0001144204-15-035361
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-06-03 20:58:46
Reporting Period:: 2015-06-01

Filing Date:: 2015-06-03
Accepted Time:: 2015-06-03 20:58:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1563665	Harvard Apparatus Regenerative Technology Inc.	HART	Surgical & Medical Instruments & Apparatus (3841)	455210462

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1449450	Thomas Mcnaughton	C/O Harvard Apparatus Regenerative Tech. 84 October Hill Road, Suite 11 Holliston MA 01746	Interim Ceo & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-06-01	3,000	$1.74	43,128	No	4	P	Direct
Common Stock	Acquisiton	2015-06-02	8,000	$1.80	51,128	No	4	P	Direct
Common Stock	Acquisiton	2015-06-03	5,000	$2.01	56,128	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $1.67 to $1.79. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes (a) a deferred stock award of 570 restricted stock units which vest on Jan 1, 2016; (b) a deferred stock award of 535 stock units which vest in equal installments on Jan 1, 2016 and Jan 1, 2017; and (c) 42,023 shares of common stock held by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $1.76 to $1.90. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes (a) a deferred stock award of 570 restricted stock units which vest on Jan 1, 2016; (b) a deferred stock award of 535 stock units which vest in equal installments on Jan 1, 2016 and Jan 1, 2017; and (c) 50,023 shares of common stock held by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $2.00 to $2.02. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes (a) a deferred stock award of 570 restricted stock units which vest on Jan 1, 2016; (b) a deferred stock award of 535 stock units which vest in equal installments on Jan 1, 2016 and Jan 1, 2017; and (c) 55,023 shares of common stock held by the Reporting Person.